{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:08:00Z","timestamp":1793941680792,"version":"4.8.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Huntington Disease (HD) is a neurodegenerative disorder in which caspase activation and cleavage of substrates, including the huntingtin protein, has been invoked as a pathological mechanism. Specific changes in caspase-2 (casp2) activity have been suggested to contribute to the pathogenesis of HD, however unique casp2 cleavage substrates have remained elusive. We thus utilized mice completely lacking casp2 (casp2-\/-) to examine the role played by casp2 in the progression of HD. This 'substrate agnostic' approach allows us to query the effect of casp2 on HD progression without pre-defining proteolytic substrates of interest.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>YAC128 HD model mice lacking casp2 show protection from well-validated motor and cognitive features of HD, including performance on rotarod, swimming T-maze, pre-pulse inhibition, spontaneous alternation and locomotor tasks. However, the specific pathological features of the YAC128 mice including striatal volume loss and testicular degeneration are unaltered in mice lacking casp2. The application of high-resolution magnetic resonance imaging (MRI) techniques validates specific neuropathology in the YAC128 mice that is not altered by ablation of casp2.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The rescue of behavioral phenotypes in the absence of pathological improvement suggests that different pathways may be operative in the dysfunction of neural circuitry in HD leading to behavioral changes compared to the processes leading to cell death and volume loss. Inhibition of caspase-2 activity may be associated with symptomatic improvement in HD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1750-1326-6-59","type":"journal-article","created":{"date-parts":[[2011,8,19]],"date-time":"2011-08-19T18:32:32Z","timestamp":1313778752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Mice lacking caspase-2 are protected from behavioral changes, but not pathology, in the YAC128 model of Huntington disease"],"prefix":"10.1186","volume":"6","author":[{"given":"Jeffrey B","family":"Carroll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber L","family":"Southwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rona K","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P","family":"Lerch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar E","family":"Ehrnhoefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ping","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagat","family":"Bissada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Mark","family":"Henkelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,19]]},"reference":[{"issue":"9557","key":"219_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"F Walker","year":"2007","unstructured":"Walker F: Huntington's disease. Lancet. 2007, 369 (9557): 218-228. 10.1016\/S0140-6736(07)60111-1.","journal-title":"Lancet"},{"issue":"6","key":"219_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington's Disease Collaborative Research Group: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993, 72 (6): 971-983. 10.1016\/0092-8674(93)90585-E.","journal-title":"Cell"},{"issue":"6","key":"219_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP: Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol. 1985, 44 (6): 559-577. 10.1097\/00005072-198511000-00003.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"219_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/sj.cdd.4402060","volume":"14","author":"S Kumar","year":"2007","unstructured":"Kumar S: Caspase function in programmed cell death. Cell Death Differ. 2007, 14 (1): 32-43. 10.1038\/sj.cdd.4402060.","journal-title":"Cell Death Differ"},{"issue":"7","key":"219_CR5","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/cdd.2008.28","volume":"15","author":"L Galluzzi","year":"2008","unstructured":"Galluzzi L, Joza N, Tasdemir E, Maiuri MC, Hengartner M, Abrams JM, Tavernarakis N, Penninger J, Madeo F, Kroemer G: No death without life: vital functions of apoptotic effectors. Cell Death Differ. 2008, 15 (7): 1113-1123. 10.1038\/cdd.2008.28.","journal-title":"Cell Death Differ"},{"issue":"4","key":"219_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/sj.cdd.4401358","volume":"11","author":"E Hermel","year":"2004","unstructured":"Hermel E, Gafni J, Propp SS, Leavitt BR, Wellington CL, Young JE, Hackam AS, Logvinova AV, Peel AL, Chen SF, et al: Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death Differ. 2004, 11 (4): 424-438. 10.1038\/sj.cdd.4401358.","journal-title":"Cell Death Differ"},{"issue":"18","key":"219_CR7","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1523\/JNEUROSCI.22-18-07862.2002","volume":"22","author":"CL Wellington","year":"2002","unstructured":"Wellington CL, Ellerby LM, Gutekunst CA, Rogers D, Warby S, Graham RK, Loubser O, van Raamsdonk J, Singaraja R, Yang YZ, et al: Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J Neurosci. 2002, 22 (18): 7862-7872.","journal-title":"J Neurosci"},{"issue":"26","key":"219_CR8","doi-asserted-by":"publisher","first-page":"19831","DOI":"10.1074\/jbc.M001475200","volume":"275","author":"CL Wellington","year":"2000","unstructured":"Wellington CL, Singaraja R, Ellerby L, Savill J, Roy S, Leavitt B, Cattaneo E, Hackam A, Sharp A, Thornberry N, et al: Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J Biol Chem. 2000, 275 (26): 19831-19838. 10.1074\/jbc.M001475200.","journal-title":"J Biol Chem"},{"issue":"15","key":"219_CR9","doi-asserted-by":"publisher","first-page":"9158","DOI":"10.1074\/jbc.273.15.9158","volume":"273","author":"CL Wellington","year":"1998","unstructured":"Wellington CL, Ellerby LM, Hackam AS, Margolis RL, Trifiro MA, Singaraja R, McCutcheon K, Salvesen GS, Propp SS, Bromm M, et al: Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem. 1998, 273 (15): 9158-9167. 10.1074\/jbc.273.15.9158.","journal-title":"J Biol Chem"},{"issue":"9","key":"219_CR10","doi-asserted-by":"publisher","first-page":"5823","DOI":"10.1074\/jbc.274.9.5823","volume":"274","author":"A Weidemann","year":"1999","unstructured":"Weidemann A, Paliga K, D\u00fcrrwang U, Reinhard FB, Schuckert O, Evin G, Masters CL: Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases. J Biol Chem. 1999, 274 (9): 5823-5829. 10.1074\/jbc.274.9.5823.","journal-title":"J Biol Chem"},{"issue":"3","key":"219_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0092-8674(00)80748-5","volume":"97","author":"FG Gervais","year":"1999","unstructured":"Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, Huang J, LeBlanc A, Smith D, Rigby M, Shearman MS, et al: Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell. 1999, 97 (3): 395-406. 10.1016\/S0092-8674(00)80748-5.","journal-title":"Cell"},{"issue":"33","key":"219_CR12","doi-asserted-by":"publisher","first-page":"23426","DOI":"10.1074\/jbc.274.33.23426","volume":"274","author":"A LeBlanc","year":"1999","unstructured":"LeBlanc A, Liu H, Goodyer C, Bergeron C, Hammond J: Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease. J Biol Chem. 1999, 274 (33): 23426-23436. 10.1074\/jbc.274.33.23426.","journal-title":"J Biol Chem"},{"issue":"17","key":"219_CR13","doi-asserted-by":"publisher","first-page":"10032","DOI":"10.1073\/pnas.1630428100","volume":"100","author":"TC Gamblin","year":"2003","unstructured":"Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, et al: Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci USA. 2003, 100 (17): 10032-10037. 10.1073\/pnas.1630428100.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"41","key":"219_CR14","doi-asserted-by":"publisher","first-page":"30150","DOI":"10.1074\/jbc.M705265200","volume":"282","author":"JE Young","year":"2007","unstructured":"Young JE, Gouw L, Propp S, Sopher BL, Taylor J, Lin A, Hermel E, Logvinova A, Chen SF, Chen S, et al: Proteolytic cleavage of ataxin-7 by caspase-7 modulates cellular toxicity and transcriptional dysregulation. J Biol Chem. 2007, 282 (41): 30150-30160. 10.1074\/jbc.M705265200.","journal-title":"J Biol Chem"},{"issue":"4","key":"219_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","volume":"94","author":"H Li","year":"1998","unstructured":"Li H, Zhu H, Xu CJ, Yuan J: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998, 94 (4): 491-501. 10.1016\/S0092-8674(00)81590-1.","journal-title":"Cell"},{"issue":"19","key":"219_CR16","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1093\/emboj\/18.19.5242","volume":"18","author":"QL Deveraux","year":"1999","unstructured":"Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC: Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. The EMBO Journal. 1999, 18 (19): 5242-5251. 10.1093\/emboj\/18.19.5242.","journal-title":"The EMBO Journal"},{"key":"219_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-1-4020-6554-5_2","volume":"615","author":"GS Salvesen","year":"2008","unstructured":"Salvesen GS, Riedl SJ: Caspase mechanisms. Adv Exp Med Biol. 2008, 615: 13-23. 10.1007\/978-1-4020-6554-5_2.","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"219_CR18","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","volume":"125","author":"RK Graham","year":"2006","unstructured":"Graham RK, Deng Y, Slow EJ, Haigh B, Bissada N, Lu G, Pearson J, Shehadeh J, Bertram L, Murphy Z, et al: Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell. 2006, 125 (6): 1179-1191. 10.1016\/j.cell.2006.04.026.","journal-title":"Cell"},{"issue":"Pt 4","key":"219_CR19","first-page":"919","volume":"132","author":"MA Pouladi","year":"2009","unstructured":"Pouladi MA, Graham RK, Karasinska JM, Xie Y, Santos RD, Peters\u00e9n A, Hayden MR: Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin. Brain. 2009, 132 (Pt 4): 919-932.","journal-title":"Brain"},{"issue":"2","key":"219_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","volume":"65","author":"AJ Milnerwood","year":"2010","unstructured":"Milnerwood AJ, Gladding CM, Pouladi MA, Kaufman AM, Hines RM, Boyd JD, Ko RWY, Vasuta OC, Graham RK, Hayden MR, et al: Early Increase in Extrasynaptic NMDA Receptor Signaling and Expression Contributes to Phenotype Onset in Huntington's Disease Mice. Neuron. 2010, 65 (2): 178-190. 10.1016\/j.neuron.2010.01.008.","journal-title":"Neuron"},{"issue":"13","key":"219_CR21","doi-asserted-by":"publisher","first-page":"8730","DOI":"10.1074\/jbc.274.13.8730","volume":"274","author":"V Galvan","year":"1999","unstructured":"Galvan V, Gorostiza OF, Banwait S, Ataie M, Logvinova AV, Sitaraman S, Carlson E, Sagi SA, Chevallier N, Jin K, et al: Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. J Biol Chem. 1999, 274 (13): 8730-8736. 10.1074\/jbc.274.13.8730.","journal-title":"J Biol Chem"},{"issue":"52","key":"219_CR22","doi-asserted-by":"publisher","first-page":"13428","DOI":"10.1523\/JNEUROSCI.4180-06.2006","volume":"26","author":"MJ Saganich","year":"2006","unstructured":"Saganich MJ, Schroeder BE, Galvan V, Bredesen DE, Koo EH, Heinemann SF: Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP. J Neurosci. 2006, 26 (52): 13428-13436. 10.1523\/JNEUROSCI.4180-06.2006.","journal-title":"J Neurosci"},{"issue":"13","key":"219_CR23","doi-asserted-by":"publisher","first-page":"8730","DOI":"10.1074\/jbc.274.13.8730","volume":"274","author":"LM Ellerby","year":"1999","unstructured":"Ellerby LM, Andrusiak RL, Wellington CL, Hackam AS, Propp SS, Wood JD, Sharp AH, Margolis RL, Ross CA, Salvesen GS, et al: Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity. J Biol Chem. 1999, 274 (13): 8730-8736. 10.1074\/jbc.274.13.8730.","journal-title":"J Biol Chem"},{"issue":"1","key":"219_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1046\/j.1471-4159.2001.t01-1-00218.x","volume":"77","author":"CM Troy","year":"2001","unstructured":"Troy CM, Rabacchi SA, Xu Z, Maroney AC, Connors TJ, Shelanski ML, Greene LA: beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation. J Neurochem. 2001, 77 (1): 157-164. 10.1046\/j.1471-4159.2001.t01-1-00218.x.","journal-title":"J Neurochem"},{"issue":"4","key":"219_CR25","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1523\/JNEUROSCI.20-04-01386.2000","volume":"20","author":"CM Troy","year":"2000","unstructured":"Troy CM, Rabacchi SA, Friedman WJ, Frappier TF, Brown K, Shelanski ML: Caspase-2 mediates neuronal cell death induced by beta-amyloid. J Neurosci. 2000, 20 (4): 1386-1392.","journal-title":"J Neurosci"},{"issue":"1","key":"219_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/jnr.1126","volume":"65","author":"JW Allen","year":"2001","unstructured":"Allen JW, Eldadah BA, Huang X, Knoblach SM, Faden AI: Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis. J Neurosci Res. 2001, 65 (1): 45-53. 10.1002\/jnr.1126.","journal-title":"J Neurosci Res"},{"issue":"5","key":"219_CR27","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0092-8674(94)90422-7","volume":"78","author":"L Wang","year":"1994","unstructured":"Wang L, Miura M, Bergeron L, Zhu H, Yuan J: Ich-1, an Ice\/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell. 1994, 78 (5): 739-750. 10.1016\/S0092-8674(94)90422-7.","journal-title":"Cell"},{"issue":"14","key":"219_CR28","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1101\/gad.8.14.1613","volume":"8","author":"S Kumar","year":"1994","unstructured":"Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA: Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme. Genes Dev. 1994, 8 (14): 1613-1626. 10.1101\/gad.8.14.1613.","journal-title":"Genes Dev"},{"issue":"4","key":"219_CR29","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/sj.cdd.4400989","volume":"9","author":"M Lamkanfi","year":"2002","unstructured":"Lamkanfi M, Declercq W, Kalai M, Saelens X, Vandenabeele P: Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death Differ. 2002, 9 (4): 358-361. 10.1038\/sj.cdd.4400989.","journal-title":"Cell Death Differ"},{"issue":"9","key":"219_CR30","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1101\/gad.10.9.1073","volume":"10","author":"D Xue","year":"1996","unstructured":"Xue D, Shaham S, Horvitz HR: The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease. Genes Dev. 1996, 10 (9): 1073-1083. 10.1101\/gad.10.9.1073.","journal-title":"Genes Dev"},{"issue":"3","key":"219_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1083\/jcb.149.3.603","volume":"149","author":"M Mancini","year":"2000","unstructured":"Mancini M, Machamer CE, Roy S, Nicholson DW, Thornberry NA, Casciola-Rosen LA, Rosen A: Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis. J Cell Biol. 2000, 149 (3): 603-612. 10.1083\/jcb.149.3.603.","journal-title":"J Cell Biol"},{"key":"219_CR32","doi-asserted-by":"publisher","first-page":"(Pt 1):161","DOI":"10.1042\/bj20030955","volume":"378","author":"B Rotter","year":"2004","unstructured":"Rotter B, Kroviarski Y, Nicolas G, Dhermy D, Lecomte M-C: AlphaII-spectrin is an in vitro target for caspase-2, and its cleavage is regulated by calmodulin binding. Biochem J. 2004, 378: (Pt 1):161-168.","journal-title":"Biochem J"},{"issue":"8","key":"219_CR33","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1091\/mbc.E04-10-0862","volume":"16","author":"T Panaretakis","year":"2005","unstructured":"Panaretakis T, Laane E, Pokrovskaja K, Bj\u00f6rklund A-C, Moustakas A, Zhivotovsky B, Heyman M, Shoshan MC, Grand\u00e9r D: Doxorubicin requires the sequential activation of caspase-2, protein kinase Cdelta, and c-Jun NH2-terminal kinase to induce apoptosis. Mol Biol Cell. 2005, 16 (8): 3821-3831. 10.1091\/mbc.E04-10-0862.","journal-title":"Mol Biol Cell"},{"issue":"46","key":"219_CR34","doi-asserted-by":"publisher","first-page":"38271","DOI":"10.1074\/jbc.M506488200","volume":"280","author":"Z Gao","year":"2005","unstructured":"Gao Z, Shao Y, Jiang X: Essential roles of the Bcl-2 family of proteins in caspase-2-induced apoptosis. J Biol Chem. 2005, 280 (46): 38271-38275. 10.1074\/jbc.M506488200.","journal-title":"J Biol Chem"},{"issue":"2","key":"219_CR35","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/sj.cdd.4402260","volume":"15","author":"GP McStay","year":"2008","unstructured":"McStay GP, Salvesen GS, Green DR: Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways. Cell Death Differ. 2008, 15 (2): 322-331. 10.1038\/sj.cdd.4402260.","journal-title":"Cell Death Differ"},{"issue":"24","key":"219_CR36","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1093\/hmg\/ddi407","volume":"14","author":"JM van Raamsdonk","year":"2005","unstructured":"van Raamsdonk JM, Murphy Z, Slow EJ, Leavitt BR, Hayden MR: Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease. Hum Mol Genet. 2005, 14 (24): 3823-3835. 10.1093\/hmg\/ddi407.","journal-title":"Hum Mol Genet"},{"issue":"16","key":"219_CR37","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","volume":"25","author":"JM Van Raamsdonk","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Slow EJ, Hossain SM, Leavitt BR, Hayden MR: Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J Neurosci. 2005, 25 (16): 4169-4180. 10.1523\/JNEUROSCI.0590-05.2005.","journal-title":"J Neurosci"},{"issue":"13","key":"219_CR38","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers DA, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N, Hossain SM, Yang Y, et al: Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet. 2003, 12 (13): 1555-1567. 10.1093\/hmg\/ddg169.","journal-title":"Hum Mol Genet"},{"issue":"8","key":"219_CR39","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/sj.cdd.4401033","volume":"9","author":"LA O'Reilly","year":"2002","unstructured":"O'Reilly LA, Ekert P, Harvey N, Marsden V, Cullen L, Vaux DL, Hacker G, Magnusson C, Pakusch M, Cecconi F, et al: Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9. Cell Death Differ. 2002, 9 (8): 832-841. 10.1038\/sj.cdd.4401033.","journal-title":"Cell Death Differ"},{"issue":"6","key":"219_CR40","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D, et al: Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet. 2006, 15 (6): 965-977. 10.1093\/hmg\/ddl013.","journal-title":"Hum Mol Genet"},{"issue":"43","key":"219_CR41","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","volume":"25","author":"M Valenza","year":"2005","unstructured":"Valenza M, Rigamonti D, Goffredo D, Zuccato C, Fenu S, Jamot L, Strand A, Tarditi A, Woodman B, Racchi M, et al: Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease. J Neurosci. 2005, 25 (43): 9932-9939. 10.1523\/JNEUROSCI.3355-05.2005.","journal-title":"J Neurosci"},{"issue":"Pt 4","key":"219_CR42","first-page":"919","volume":"132","author":"MA Pouladi","year":"2009","unstructured":"Pouladi MA, Graham RK, Karasinska JM, Xie Y, Santos RD, Peters\u00e9n A, Hayden MR: Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin. Brain: a journal of neurology. 2009, 132 (Pt 4): 919-932.","journal-title":"Brain: a journal of neurology"},{"issue":"43","key":"219_CR43","doi-asserted-by":"publisher","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","volume":"29","author":"AL Southwell","year":"2009","unstructured":"Southwell AL, Ko J, Patterson PH: Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington&apos;s disease. J Neurosci. 2009, 29 (43): 13589-13602. 10.1523\/JNEUROSCI.4286-09.2009.","journal-title":"J Neurosci"},{"issue":"5","key":"219_CR44","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1162\/jocn.2003.15.5.629","volume":"15","author":"AR Aron","year":"2003","unstructured":"Aron AR, Watkins L, Sahakian BJ, Monsell S, Barker RA, Robbins TW: Task-set switching deficits in early-stage Huntington's disease: implications for basal ganglia function. J Cogn Neurosci. 2003, 15 (5): 629-642. 10.1162\/jocn.2003.15.5.629.","journal-title":"J Cogn Neurosci"},{"issue":"Pt 5","key":"219_CR45","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/brain\/119.5.1633","volume":"119","author":"AD Lawrence","year":"1996","unstructured":"Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, Robbins TW: Executive and mnemonic functions in early Huntington's disease. Brain. 1996, 119 (Pt 5): 1633-1645.","journal-title":"Brain"},{"issue":"2","key":"219_CR46","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bbr.2007.01.006","volume":"178","author":"R Lalonde","year":"2007","unstructured":"Lalonde R, Qian S: Exploratory activity, motor coordination, and spatial learning in Mchr1 knockout mice. Behav Brain Res. 2007, 178 (2): 293-304. 10.1016\/j.bbr.2007.01.006.","journal-title":"Behav Brain Res"},{"issue":"2","key":"219_CR47","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1136\/jnnp.58.2.192","volume":"58","author":"NR Swerdlow","year":"1995","unstructured":"Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, Swenson MR: Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatr. 1995, 58 (2): 192-200. 10.1136\/jnnp.58.2.192.","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"43","key":"219_CR48","doi-asserted-by":"publisher","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","volume":"29","author":"AL Southwell","year":"2009","unstructured":"Southwell AL, Ko J, Patterson PH: Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease. J Neurosci. 2009, 29 (43): 13589-13602. 10.1523\/JNEUROSCI.4286-09.2009.","journal-title":"J Neurosci"},{"issue":"3","key":"219_CR49","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.nbd.2007.01.006","volume":"26","author":"JM Van Raamsdonk","year":"2007","unstructured":"Van Raamsdonk JM, Murphy Z, Selva DM, Hamidizadeh R, Pearson J, Peters\u00e9n A, Bj\u00f6rkqvist M, Muir C, Mackenzie IR, Hammond GL, et al: Testicular degeneration in Huntington disease. Neurobiol Dis. 2007, 26 (3): 512-520. 10.1016\/j.nbd.2007.01.006.","journal-title":"Neurobiol Dis"},{"key":"219_CR50","volume-title":"Neurobiol Dis","author":"JB Carroll","year":"2011","unstructured":"Carroll JB, Lerch JP, Franciosi S, Spreeuw A, Bissada N, Henkelman RM, Hayden MR: Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington Disease. Neurobiol Dis. 2011"},{"issue":"1","key":"219_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neuroimage.2008.03.037","volume":"42","author":"AE Dorr","year":"2008","unstructured":"Dorr AE, Lerch JP, Spring S, Kabani N, Henkelman RM: High resolution three-dimensional brain atlas using an average magnetic resonance image of 40 adult C57Bl\/6J mice. NeuroImage. 2008, 42 (1): 60-69. 10.1016\/j.neuroimage.2008.03.037.","journal-title":"NeuroImage"},{"issue":"2","key":"219_CR52","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuroimage.2008.02.019","volume":"41","author":"JP Lerch","year":"2008","unstructured":"Lerch JP, Carroll JB, Dorr A, Spring S, Evans AC, Hayden MR, Sled JG, Henkelman RM: Cortical thickness measured from MRI in the YAC128 mouse model of Huntington&apos;s disease. NeuroImage. 2008, 41 (2): 243-251. 10.1016\/j.neuroimage.2008.02.019.","journal-title":"NeuroImage"},{"issue":"1","key":"219_CR53","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neuroimage.2007.08.033","volume":"39","author":"JP Lerch","year":"2008","unstructured":"Lerch JP, Carroll JB, Spring S, Bertram LN, Schwab C, Hayden MR, Henkelman RM: Automated deformation analysis in the YAC128 Huntington disease mouse model. NeuroImage. 2008, 39 (1): 32-39. 10.1016\/j.neuroimage.2007.08.033.","journal-title":"NeuroImage"},{"key":"219_CR54","volume-title":"Neuroimage","author":"JP Lerch","year":"2008","unstructured":"Lerch JP, Carroll JB, Spring S, Bertram LN, Schwab C, Hayden MR, Mark Henkelman R: Automated deformation analysis in the YAC128 Huntington disease mouse model. Neuroimage. 2008, 39:"},{"issue":"1","key":"219_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biopsych.2005.06.003","volume":"59","author":"JS Paulsen","year":"2006","unstructured":"Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, Nopoulos PC: Brain structure in preclinical Huntington's disease. Biol Psychiatry. 2006, 59 (1): 57-63. 10.1016\/j.biopsych.2005.06.003.","journal-title":"Biol Psychiatry"},{"issue":"Pt 1","key":"219_CR56","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/brain\/118.1.145","volume":"118","author":"R Sprengelmeyer","year":"1995","unstructured":"Sprengelmeyer R, Lange H, H\u00f6mberg V: The pattern of attentional deficits in Huntington's disease. Brain. 1995, 118 (Pt 1): 145-152.","journal-title":"Brain"},{"issue":"Pt 7","key":"219_CR57","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/brain\/121.7.1329","volume":"121","author":"AD Lawrence","year":"1998","unstructured":"Lawrence AD, Hodges JR, Rosser AE, Kershaw A, ffrench-Constant C, Rubinsztein DC, Robbins TW, Sahakian BJ: Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain. 1998, 121 (Pt 7): 1329-1341.","journal-title":"Brain"},{"issue":"1","key":"219_CR58","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1471-4159.2005.03357.x","volume":"95","author":"JM Van Raamsdonk","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Bailey CDC, Rogers DA, Johnson GVW, Hayden MR, Leavitt BR: Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease. J Neurochem. 2005, 95 (1): 210-220. 10.1111\/j.1471-4159.2005.03357.x.","journal-title":"J Neurochem"},{"issue":"2","key":"219_CR59","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.expneurol.2005.07.021","volume":"196","author":"JM Van Raamsdonk","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Rogers DA, Lu G, Barakauskas VE, Barr AM, Honer WG, Hayden MR, Leavitt BR: Ethyl-EPA treatment improves motor dysfunction, but not neurodegeneration in the YAC128 mouse model of Huntington disease. Exp Neurol. 2005, 196 (2): 266-272. 10.1016\/j.expneurol.2005.07.021.","journal-title":"Exp Neurol"},{"issue":"3","key":"219_CR60","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","volume":"66","author":"HS Group","year":"2006","unstructured":"Group HS: Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial. Neurology. 2006, 66 (3): 366-372.","journal-title":"Neurology"},{"issue":"6","key":"219_CR61","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/mrm.21077","volume":"56","author":"RM Henkelman","year":"2006","unstructured":"Henkelman RM, Baghdadi L, Sled JG: Presentation of 3D isotropic imaging data for optimal viewing. Magn Reson Med. 2006, 56 (6): 1371-1374. 10.1002\/mrm.21077.","journal-title":"Magn Reson Med"},{"issue":"1","key":"219_CR62","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neuroimage.2008.03.037","volume":"42","author":"AE Dorr","year":"2008","unstructured":"Dorr AE, Lerch JP, Kabani N, Henkelman RM: High resolution three-dimensional brain atlas using an average magnetic resonance image of 40 adult C57Bl\/6J mice. Neuroimage. 2008, 42 (1): 60-69. 10.1016\/j.neuroimage.2008.03.037.","journal-title":"Neuroimage"},{"issue":"3","key":"219_CR63","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/hbm.460030304","volume":"3","author":"D Collins","year":"1995","unstructured":"Collins D, Holmes C, Peters T, Evans A: Automatic 3-D model-based neuroanatomical segmentation. Human Brain Mapping. 1995, 3 (3): 190-208. 10.1002\/hbm.460030304.","journal-title":"Human Brain Mapping"},{"key":"219_CR64","first-page":"104530","volume-title":"Society for Neuroscience","author":"J Lerch","year":"2007","unstructured":"Lerch J, Yiu A, Bohbot V, Henkelman R, Josselyn S, Sled J: Morris water maze training induces changes in brain shape detectable by MRI. Society for Neuroscience. 2007, 104530-"},{"key":"219_CR65","volume-title":"R: A Language and Environment for Statistical Computing","author":"RDC Team","year":"2009","unstructured":"Team RDC: R: A Language and Environment for Statistical Computing. 2009"},{"issue":"6","key":"219_CR66","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D, et al: Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet. 2006, 15 (6): 965-977. 10.1093\/hmg\/ddl013.","journal-title":"Hum Mol Genet"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1326-6-59.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T16:20:47Z","timestamp":1630513247000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/1750-1326-6-59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,19]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["219"],"URL":"https:\/\/doi.org\/10.1186\/1750-1326-6-59","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,19]]},"assertion":[{"value":"10 May 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"59"}}